Sign Up
Sign in
en
ru
News
Foundation
Technopark
Город
Education
Search
/
Foundation
/
Biomedical Cluster
/
News
Goals
Направления
Participants
Partners
Info Partners
Results
Biomed Library
All site RSS
Events
Cluster News
In northern Russia, innovators look to the forests and the sea
When pinpointing a region’s innovative potential, it may not seem entirely logical to look to a seaweed-processing plant preparing to celebrate its centenary. But Russia’s northern Arkhangelsk...
17.04.2017,
Статьи
The northern way: Arkhangelsk governor urges startups to buck the trend
ARKHANGELSK — Conditions in the Far North are not easy, and the people who live there are the first to acknowledge that. The Russian government agrees, and in compensation for the long, harsh winters...
11.04.2017,
Статьи
Subarctic innovations: Startup Tour visits Arkhangelsk
ARKHANGELSK — The Open Innovations Startup Tour, the Skolkovo Foundation’s annual roving quest for talented tech startups, kicked off its first visit to the northern Russian city of Arkhangelsk...
10.04.2017,
Статьи
Cancer vaccine shows promising results in clinical trials
SL Onkolodzhi, a Skolkovo resident startup working on a cancer vaccine, has successfully completed phase I/IIa clinical trials together with its U.S. partner, CureLab Oncology, Inc. The two companies have...
07.04.2017,
Новости
Half of Russian innovative drugs are made in Skolkovo
Half of all Russian-origin innovative pharmaceuticals are developed by Skolkovo Foundation startups, Kirill Kaem, head of the organisation’s biomed cluster, told a meeting of the foundation’s...
28.03.2017,
Новости
Skolkovo’s first unicorn? Cattle embryo startup impresses major Russian meat producer
Just four months after Cherkizovo Group, one of Russia’s biggest meat producers, signed an agreement with the Skolkovo Technopark to set up an agrotech accelerator there, the company has already...
28.03.2017,
Статьи
Skolkovo startup Infectex completes clinical trials of groundbreaking new TB drug
Infectex, a resident of the Skolkovo Foundation’s biomed cluster, has completed clinical trials in Russia of its new drug for treating TB, the company announced on Friday, World Tuberculosis Day...
27.03.2017,
Новости
South Korean startups parachute in to Skolkovo for soft landing
The Skolkovo innovation city could soon be welcoming its first resident startups from South Korea, if applications from four companies currently taking part in a soft landing programme here are successful...
23.03.2017,
Статьи
Fashion of the future: Skolkovo startups present innovations at Russian fashion week
Amid the hazardous hairstyles and improbable outfits on display at the Mercedes-Benz Fashion Week Russia last week, it was hard to stand out. But in one of the cavernous rooms of Moscow’s Manezh...
21.03.2017,
Статьи
Panasonic to launch pilot hi-tech agricultural project at Skolkovo
Japan’s Panasonic Corporation may be primarily associated in the public mind with consumer electronics, but in some parts of the world, it is selling a very different kind of product: vegetables...
13.02.2017,
Статьи
Open Innovations Startup Tour completes its first leg with stop in Almaty
The Open Innovations Startup Tour 2017, a roving search for talented tech startups across Russia and several neighbouring countries, has completed its first stop abroad in the Kazakh city of Almaty, following...
10.02.2017,
Новости
Startup Tour kicks off in subarctic city of Yakutsk
This year’s Open Innovations Startup Tour, the Skolkovo Foundation’s annual roving quest for talented tech startups across Russia and neighbouring countries, began Monday in the northern city...
30.01.2017,
Статьи
Skolkovo plans to set up aquaculture centre of excellence in Russia’s Far East
The gigantic oceanarium that opened in Russia’s Far East last year could become a centre of excellence in aquaculture with the help of the Skolkovo innovation centre. The Primorsky Oceanarium opened...
09.01.2017,
Статьи
ESMO Asia 2016: First-in-class inhibitor of FGFR2 shows promising results in preclinical studies
SINGAPORE – A novel allosteric fibroblast growth factor receptor 2 (FGFR2) inhibitor, alofanib, has potent anti-tumour and antiangiogenic activity, according to the results of preclinical studies...
21.12.2016,
Пресс-релизы
T8, Ensim included on list of top Russian fast-growing tech companies
Two Skolkovo resident startups were included in the TekhUspekh (TechUp) rating of fast-growing Russian tech companies announced at Moscow State University last week. Eidos (Ensim), which makes surgery...
13.12.2016,
Новости
<
>